On 06-dec-2023, a spontaneous report was received from the fda via email regarding a 13-year-old female who used a thermacare menstrual heat wrap.On an unspecified date, the consumer topically applied a thermacare menstrual heat wrap for an unspecified indication.The consumer was noted to have used the heat wrap as directed.On an unspecified date, after using the heat wrap the consumer experienced burns and blisters.The consumer noted there was no warning about the burns she experienced.No additional information was provided.
|
The root cause cannot be identified.There is limited device specific information provided, no batch number was available for evaluation.Without a batch reference number, a manufacturing and technical evaluation cannot be completed for the wrap involved in this case.No product quality related trend was identified for the subclass adverse event safety request for investigation for menstrual products.Care should be taken when using the device, following all safety and use information as provided with the wrap to avoid the risk of blisters and other skin irritations.The manufacturing operations employ quality control procedures which include in process testing, thermal testing and visual inspection, to ensure packaged product quality.There are pre-identified risk factors that could cause a burn listed in the hazard analysis (rpt-000097160).In addition to these hazards, there are multiple risks that are outside the control of the site.These include things like age, skin condition, medical conditions, device use error and off-label use.The warning labels on our product are used to address these risks and relay the appropriate instructions for use to our customers to avoid burns, blisters and skin irritations.
|